We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-12.77%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$44.2B
AUM Growth
-$8.44B
(-16%)
Cap. Flow
-$301M
Cap. Flow
% of AUM
-0.68%
Top 10 Holdings %
Top 10 Hldgs %
14.01%
Holding
2,360
New
150
Increased
1,005
Reduced
998
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$209M |
| 2 |
CVS Health
CVS
|
+$195M |
| 3 |
Tyson Foods
TSN
|
+$136M |
| 4 |
ExxonMobil
XOM
|
+$135M |
| 5 |
LyondellBasell Industries
LYB
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$239M |
| 2 |
Microsoft
MSFT
|
+$204M |
| 3 |
Johnson & Johnson
JNJ
|
+$157M |
| 4 |
Amazon
AMZN
|
+$144M |
| 5 |
Walmart Inc
WMT
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.23% |
| 2 | Healthcare | 16.49% |
| 3 | Financials | 11.74% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
Innovative Industrial Properties
IIPR
$1.67B
| $548K | ﹤0.01% |
4,988
+79
| +2% | +$11.2K |
|
|
ECHO
1652
EchoStar
ECHO
$25.7B
| $547K | ﹤0.01% |
28,469
+16,322
| +134% | +$369K |
|
1653
Santander
BSBR
$43.7B
| $546K | ﹤0.01% |
99,393
-29,373
| -23% | -$196K |
|
1654
Empire State Realty Trust
ESRT
$807M
| $545K | ﹤0.01% |
79,317
+58,671
| +284% | +$477K |
|
1655
Addus HomeCare
ADUS
$2.23B
| $544K | ﹤0.01% |
6,528
+220
| +3% | +$18.5K |
|
1656
First Solar
FSLR
$26.6B
| $544K | ﹤0.01% |
8,245
-24,058
| -74% | -$1.71M |
|
1657
Grid Dynamics Holdings
GDYN
$618M
| $544K | ﹤0.01% |
32,352
-80,667
| -71% | -$1.32M |
|
|
KAMN
1658
DELISTED
Kaman Corp
KAMN
| $542K | ﹤0.01% |
17,352
-1,756
| -9% | -$65.1K |
|
|
PRTY
1659
DELISTED
Party City Holdco Inc.
PRTY
| $541K | ﹤0.01% |
409,777
+268,308
| +190% | +$593K |
|
1660
Artisan Partners
APAM
$3.02B
| $539K | ﹤0.01% |
15,156
-18,634
| -55% | -$678K |
|
1661
LeMaitre Vascular
LMAT
$1.88B
| $539K | ﹤0.01% |
11,839
-8,693
| -42% | -$389K |
|
|
PMT
1662
PennyMac Mortgage Investment
PMT
$820M
| $538K | ﹤0.01% |
38,868
-7,665
| -16% | -$117K |
|
|
AUD
1663
DELISTED
Audacy, Inc.
AUD
| $537K | ﹤0.01% |
569,540
+478,889
| +528% | +$960K |
|
|
VRNT
1664
DELISTED
Verint Systems
VRNT
| $532K | ﹤0.01% |
12,557
+2,901
| +30% | +$145K |
|
1665
Century Aluminum
CENX
$5.25B
| $530K | ﹤0.01% |
71,934
+57,755
| +407% | +$898K |
|
1666
TFS Financial
TFSL
$4.85B
| $528K | ﹤0.01% |
38,480
-422
| -1% | -$6.21K |
|
|
MAXR
1667
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $528K | ﹤0.01% |
20,221
-7,812
| -28% | -$243K |
|
|
CSII
1668
DELISTED
Cardiovascular Systems, Inc.
CSII
| $527K | ﹤0.01% |
36,723
-4,174
| -10% | -$72.4K |
|
1669
Harmony Biosciences
HRMY
$2.27B
| $523K | ﹤0.01% |
+10,723
| New | +$483K |
|
|
IEA
1670
DELISTED
Infrastructure and Energy Alternatives, Inc. Common Stock
IEA
| $523K | ﹤0.01% |
65,116
-10,629
| -14% | -$99.4K |
|
1671
Madison Square Garden
MSGS
$9.41B
| $520K | ﹤0.01% |
3,487
+1,592
| +84% | +$258K |
|
1672
CRISPR Therapeutics
CRSP
$5.18B
| $517K | ﹤0.01% |
8,505
-578
| -6% | -$34K |
|
1673
Kinetik
KNTK
$4.16B
| $517K | ﹤0.01% |
15,146
-1,206
| -7% | -$44.7K |
|
1674
Stride
LRN
$3.34B
| $517K | ﹤0.01% |
12,672
+714
| +6% | +$26.4K |
|
|
ZYXI
1675
DELISTED
Zynex
ZYXI
| $516K | ﹤0.01% |
64,696
+38,462
| +147% | +$272K |
|
Similar funds
VGA
AQR Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, AQR Capital Management held 2,360 positions worth $44.2B, down 16% from $52.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AQR Capital Management's Q2 2022 filing shows 150 new, 1,005 increased, 998 reduced and 187 closed positions. Its largest new stake was Fluor: 339,891 shares worth $7.86M. The largest sale was Thermo Fisher Scientific, an estimated $239M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q2 2022 buy was Fluor: 339,891 shares worth $7.86M.
- AQR Capital Management added most to Gilead Sciences in Q2 2022, an estimated $209M increase.
- AQR Capital Management's biggest Q2 2022 reduction was Thermo Fisher Scientific, cutting an estimated $239M.
- AQR Capital Management fully exited Roku in Q2 2022, selling an estimated $32.5M.
- AQR Capital Management's ten largest holdings make up 14% of its $44.2B portfolio in Q2 2022.
- AQR Capital Management opened 150 new positions and closed 187 in Q2 2022.
- AQR Capital Management's portfolio value fell 16% quarter-over-quarter to $44.2B.
Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.